Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moussa B H Youdim

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|February 19, 2010
Rasagiline in Parkinson's diseaseMoussa B H Youdim
Parkinsonism & Related Disorders|December 15, 2011
M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal modelsMoussa B H Youdim
Rambam Maimonides Medical Journal|August 3, 2013
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|February 22, 2022
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapyMoussa B H Youdim
Experimental Neurobiology|November 24, 2011
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agentsMoussa B H Youdim
Current Alzheimer Research|December 16, 2006
The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|October 21, 2018
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseasesMoussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|April 8, 2022
Treatment; Moussa B.H. YoudimMoussa B H Youdim
Experimental Neurobiology|April 16, 2013
Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagilineMoussa B H Youdim
Free Radical Biology & Medicine|June 30, 2004
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseasesSilvia Mandel, Moussa B H Youdim
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|February 19, 2010
Rasagiline in Parkinson's diseaseMoussa B H Youdim
Parkinsonism & Related Disorders|December 15, 2011
M30, a brain permeable multitarget neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal modelsMoussa B H Youdim
Rambam Maimonides Medical Journal|August 3, 2013
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|February 22, 2022
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapyMoussa B H Youdim
Experimental Neurobiology|November 24, 2011
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agentsMoussa B H Youdim
Current Alzheimer Research|December 16, 2006
The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|October 21, 2018
Monoamine oxidase inhibitors, and iron chelators in depressive illness and neurodegenerative diseasesMoussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)|April 8, 2022
Treatment; Moussa B.H. YoudimMoussa B H Youdim
Experimental Neurobiology|April 16, 2013
Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagilineMoussa B H Youdim
Free Radical Biology & Medicine|June 30, 2004
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseasesSilvia Mandel, Moussa B H Youdim
Pageof 21